Aurora has received all necessary regulatory approvals to launch the study, which will include data from 40 single-level and 40 multilevel cases, according to a June 28 press release.
The Dexa-C system is the first in a series of implants based on Aurora’s patented Dexa technology platform, which includes implants varying in density to best match a patient’s bones.
Dexa-C is intended for use on patients who require anterior cervical discectomy and fusion surgery, implanting an interbody spacer into the cervical intervertebral body space to stabilize and fuse the level.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
